GW Pharma releases pricing on newly approved CBD-drug
Insured patients in the USA would pay up to $200 per month for CBD-based drug Epidiolex under a recent pricing announcement from the maker, UK-based GW Pharmaceuticals. Epidiolex is the […]
GW Pharma releases pricing on newly approved CBD-drug Read More »